Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AstraZeneca PLC Consolidating 350 California Jobs to the Bay Area

AstraZeneca, with worldwide headquarters in Cambridge, UK, announced that it is consolidating some of its California staffers at The Cove at Oyster Point in South San Francisco.

Read More »

ADHD drugs no help with homework

Giving stimulants to kids with attention deficit hyperactivity disorder (ADHD) may not help them complete homework or get better grades, a small study suggests.

Read More »

Americas becomes first region to eliminate measles: health agency

The Americas has become the first region in the world to be free of measles, following a 22-year vaccination drive against the disease which continues to infect tens of thousands of people globally, the Pan American Health Organization said.

Read More »

Amgen’s Kyprolis falls short in study

Amgen’s multiple myeloma drug did not fare better than Takeda’s older therapy Velcade in a study involving patients who had not yet been treated for the disease.

Read More »

Kite Pharma Claims Success for Phase II CAR-T Study, Stock Soars

Shares of Kite Pharma were up after the company’s CAR-T therapy KTE-C19 demonstrated a 39 percent response rate, including a complete response rate of one-third of patients with various forms of Non-Hodgkin’s Lymphoma after three months of treatment, the company announced.

Read More »

Bristol-Myers to test Opdivo with Nektar drug

Bristol-Myers Squibb will evaluate the use of its blockbuster immunotherapy Opdivo with an experimental drug from Nektar Therapeutics to treat multiple cancers.

Read More »

Shire Terminates a Couple of Biosimilar Deals Made by Baxalta

After a strategic review of its portfolio after its acquisition of Baxalta, Shire has terminated two biosimilar deals: one with Momenta Pharmaceuticals and the other with Coherus Biosciences.

Read More »

Sanofi gets $43 million U.S. funding to spur Zika vaccine development

Sanofi SA said the U.S. Department of Health and Human Services (HHS) approved $43.18 million in funding to accelerate the development of a Zika vaccine, as efforts to prevent the infection gather momentum.

Read More »

3 Facts Life Sciences Companies Need to Know About Medical Claims

There are 3 key facts life sciences companies need to know about real-time or near real-time medical claims data to support timely business decision-making.

Read More »

Mylan faces scrutiny over EpiPen profit data shown to Congress

Mylan NV faced questions about the profit on its EpiPen emergency allergy treatment, following a report that the company makes 60 percent more on the injector than it had told Congress.

Read More »

Pfizer abandons plan to split into two companies

Pfizer, which was considering a split into two companies for more than two years, said it would not do so because the move would not create any shareholder value.

Read More »

FDA approves J&J’s Stelara for Crohn’s disease

Johnson & Johnson said the U.S. Food and Drug Administration approved the company’s blockbuster psoriasis drug Stelara for adults with Crohn’s disease.

Read More »

Third win for cannabis drug in epilepsy sends GW to record high

An experimental cannabis-derived drug has successfully treated children with severe epilepsy in a third late-stage clinical trial, sending shares in Britain’s GW Pharmaceuticals to a record high.

Read More »

Vela Diagnostics gets emergency U.S. authorization for Zika test

Vela Diagnostics said its test for the Zika virus had received “emergency use authorization” from the U.S. Food and Drug Administration.

Read More »

PerkinElmer Reorganizes and Splits Into Two Business Segments

On the same day that Pfizer announced it would not break into two companies, Waltham, Mass.-based PerkinElmer announced that it was breaking into two separate companies.

Read More »

North Carolina’s Biologics Inc. to Pink Skip Another 132 Workers

Five months after its acquisition by McKesson Corp. was finalized as part of a $1.2 billion deal, North Carolina-based Biologics Inc. announced it was terminating 132 employees, the Triangle Business Journal reported.

Read More »

FDA approves Amgen’s copy of AbbVie arthritis drug Humira

The U.S. Food and Drug Administration approved Amgen’s biosimilar version of AbbVie’s top-selling arthritis drug Humira.

Read More »

Endo CEO steps down; successor named

Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli.

Read More »

Six in the running to be next World Health Organization leader

Six international health experts, including four from Europe, are to compete to become the next director general of the World Health Organization (WHO) after its current leader Margaret Chan ends her tenure in June 2017.

Read More »

UPS launches U.S. drone test flights for urgent medical deliveries

United Parcel Service Inc. said it began testing the use of drones for emergency deliveries of medical supplies with a flight in rural Massachusetts, which the company hopes will eventually lead to federal approval of drones as a regular delivery option.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom